Perinatal mortality · Women with a multiple pregnancy
Vaginal progesterone showed no clear difference in perinatal death compared with no treatment or placebo (low certainty).
1 finding from 1 review
Preterm birth less than 34 weeks' gestation · Women with a multiple pregnancy
Vaginal progesterone showed no clear difference in preterm birth less than 34 weeks compared with no treatment or placebo (low certainty).
1 finding from 1 review
Major neurodevelopmental disability at childhood · Women with a multiple pregnancy
1 finding from 1 review
Falls · people with multiple sclerosis
It is very uncertain whether exercise changes falls rate Falls were measured using prospective daily diaries,… compared with control (post‐intervention) (very low certainty).
1 finding from 1 review
Number of fallers · people with multiple sclerosis
Exercise showed no clear difference in number of fallers Falls were measured using prospective daily… compared with control (post‐intervention) (low certainty).
1 finding from 1 review
Adverse events The timing of measurement was post‐intervention for all studies · people with multiple sclerosis
Exercise showed no clear difference in adverse events The timing of measurement was post‐intervention for… compared with control (post‐intervention) (low certainty).
1 finding from 1 review
Quality of life · people with multiple sclerosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life Assessed by: SeiQoL‐DW (higher scores mean better quality of life) · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
1 finding from 1 review
Adverse effects: at least one serious adverse event · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
Palliative care showed no clear difference in serious adverse events Assessed by: number of participants… compared with usual care (low certainty).
1 finding from 1 review
Hospital admissions · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
Palliative care showed no clear difference in hospital admission Assessed by: number of participants admitted in… compared with usual care (low certainty).
1 finding from 1 review
Fatigue ‐ Not reported at long term · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Disability ‐ Not reported at long term · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety ‐ not reported · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depression ‐ Not reported at long term · adults with multiple sclerosis Interventions: immunosuppressive and immunomodulatory drugs Comparator: placebo Outcome: withdrawals due to…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Polyneuropathies · newly diagnosed, transplant‐ineligible adults with symptomatic multiple myeloma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Serious adverse events · newly diagnosed, transplant‐ineligible adults with symptomatic multiple myeloma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Withdrawals due to adverse events · newly diagnosed, transplant‐ineligible adults with symptomatic multiple myeloma
1 finding from 1 review
no estimate extracted
82 participants
GRADE not reported
Intervention not reported
Quality of life · newly diagnosed, transplant‐ineligible adults with symptomatic multiple myeloma
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Keratinized tissue width change · Adult patients with multiple recession-type defects (Miller Class I/II, at least 3 mm)
PRF + CAF showed no clear difference in keratinized tissue width change compared with SCTG + CAF; GRADE not reported.
1 finding from 1 review
MD -0.26 [-0.98, 0.45]
2 studies
GRADE not reported
Occurrence of adverse effects or postoperative complications · Adult patients with multiple recession-type defects (Miller Class I/II, at least 3 mm)
1 finding from 1 review